YOUR WELLNESS SPACEThe nutrition library
p+proof&priceMADE FOR INDIAAsk us
THE CATEGORY GUIDE

PQQ

Preliminary cognition research does not prove mitochondrial rejuvenation.

PQQ, pyrroloquinoline quinone, is a compound sold for cognitive and mitochondrial-health claims. Much of the mechanistic enthusiasm comes from laboratory work, while human evidence is limited and does not establish a general need for supplementation.

Brand-independent category guide · Sources checked 2 November 2026
START HERE

Three things to remember

  1. A small cognitive trial is not proof of dementia prevention or slower aging.
  2. PQQ disodium salt and a larger proprietary complex need clear active labelling.
  3. A safety assessment under specific conditions is not a recommended daily intake.

Interpret cognitive findings narrowly

A 12-week placebo-controlled trial reported improvements on selected memory measures with PQQ disodium salt. Some findings came from age-subgroup analyses. The authors included employees of the ingredient manufacturer, and the study does not establish broad clinical benefit across populations.

Test performance, daily functioning and prevention of dementia are different endpoints. A laboratory claim about mitochondria cannot replace a human outcome trial. Current evidence does not establish that PQQ reverses aging, increases human lifespan or reliably treats unexplained fatigue.

Sources: Pyrroloquinoline quinone disodium salt and cognitive function, 2023 — Tamakoshi et al., Food & Function ↗

The salt and its specifications matter

PQQ disodium salt is the form in the cited trial and EFSA safety assessment. Products may combine it with CoQ10 or other compounds and call the mixture a mitochondrial complex. That description does not establish the active PQQ quantity.

A claim linked to a particular ingredient specification should match that specification. The same acronym on two bottles does not demonstrate equal purity, stability or clinical effects. A combination also requires attention to its other ingredients rather than inheriting the safety conclusions for PQQ alone.

Sources: Pyrroloquinoline quinone disodium salt and cognitive function, 2023 — Tamakoshi et al., Food & Function ↗ · Safety of pyrroloquinoline quinone disodium salt as a novel food, 2017 — EFSA ↗

Do not confuse a blend total with PQQ

Hypothetical example: a 120 mg complex provides 10 mg PQQ disodium salt plus other ingredients. Two capsules containing that complex each would supply 20 mg of the declared salt, not 240 mg PQQ. A 60-capsule bottle at ₹1,800 has 30 two-capsule servings costing ₹60 each.

These figures illustrate label arithmetic, not a recommended regimen. A PQQ-equivalent statement must explain its chemical basis. When the active amount is undisclosed, the honest comparison is unknown rather than an assumed percentage.

Read the boundaries of the assessment

EFSA assessed a specified PQQ disodium-salt product for healthy adults at an intended maximum 20 mg daily, excluding pregnant and breastfeeding women and children. This is a defined safety assessment, not proof of benefit, a universal safe limit for every product or an intake target.

Human information on long-term exposure and medicine interactions remains limited. A small trial without a clear safety signal cannot rule out uncommon harms. People with illness or multiple medicines should not assume that the healthy-adult assessment applies to their situation.

Sources: Safety of pyrroloquinoline quinone disodium salt as a novel food, 2017 — EFSA ↗

Quality cannot substitute for missing efficacy

Useful product fields include exact salt, active amount, additional ingredients, batch analysis and serving count. Purity testing can answer whether the product contains what it claims. It cannot show that the consumer will think more clearly or age more slowly.

Compare cost for the same disclosed ingredient and amount, but keep the uncertainty visible. A premium for mitochondrial support needs meaningful human evidence, not only a pathway illustration. There is no established PQQ deficiency-based requirement for routine supplementation in this guide.

Sources: Safety of pyrroloquinoline quinone disodium salt as a novel food, 2017 — EFSA ↗

Common questions

Is EFSA assessment the same as a recommendation to take PQQ?

No. It evaluates safety within specified conditions and populations. It does not establish a clinical benefit or routine need.

Does a memory-test finding prove dementia prevention?

No. Prevention requires different evidence, longer follow-up and clinically relevant outcomes.

WHEN YOU’RE READY TO COMPARE

Take the knowledge with you.

Compare the same form, active amount and intended use before comparing price. India and International listings have separate filters; some categories may have no listings in one market. Listings do not establish local stock or a need for a supplement. Shopping disclosures appear on product pages.

Sources & scope

This is a brand-independent editorial summary of the sources below, not an independent clinical review. Published reference values apply to their stated populations. Ingredient research does not verify a particular brand, batch or seller. No individual diagnosis, deficiency test or medical assessment is performed here.

Product photo credits & licences